Capital One National Association’s iShares Biotechnology ETF IBB Stock Holding History

Capital One National Association’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$852K	Buy	+7,067	New	+$788K	0.11%	163

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital One National Association's IBB Position: Q4 2019 in Review

Capital One National Association opened a new position in iShares Biotechnology ETF (IBB) in Q4 2019: 7,067 shares worth $852K. The stake represents 0.11% of the portfolio and ranks #163 among its holdings.

710 funds tracked by Wall St. Rank hold IBB as of Q4 2019.

Capital One National Association held 7,067 shares of iShares Biotechnology ETF worth $852K as of Q4 2019.
iShares Biotechnology ETF was a new Capital One National Association position in Q4 2019.
iShares Biotechnology ETF made up 0.11% of Capital One National Association's portfolio in Q4 2019, its #163 holding.
710 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2019.

Based on Capital One National Association's 13F filing for Q4 2019, filed 11 Feb 2020.